Evidence status for Contrast-Enhanced Ultrasound (CEUS) in Lung Cancer Diagnosis
The provided statements describe emerging CEUS methods for lung cancer characterization, but they are not established as guideline-recommended alternatives to contrast-enhanced CT for routine diagnosis in most clinical pathways. [No guideline source was provided in the text to support “comparable to CECT” accuracy.]
Clarification of the Requested Output
A focused response can be generated in one of two directions:
- Evidence appraisal of the specific claims in the text (diagnostic accuracy comparisons, CPI/perfusion-pattern interpretations, TIC/logistic-model performance, obstructive atelectasis resolution, and CEUS-guided biopsy/ROSE synergy).
- Clinical integration summary (where CEUS fits in diagnostic algorithms, typical use-cases, contraindications/limitations, and how CEUS outputs should be operationalized for biopsy planning).
Specific Claims Requiring Re-Verification
Several numeric and mechanistic assertions in the text require confirmation against the cited sources because they are unusually precise and depend on study design (patient selection, reference standard, lesion type, operator experience, software algorithm, and whether CECT was truly the comparator).
The items most in need of source-confirmed verification are:
- Diagnostic accuracy equivalence to CECT for peripheral pulmonary malignancies.
- Inter-observer variability and “76.5% to >90.4%” improvements attributed to CPI.
- The stated perfusion-timing thresholds (eg, arrival time ≥10 seconds vs <10 seconds) across bronchial vs pulmonary arterial supply.
- The “C-statistics above 0.97” for the “six-metric” logistic models.
- The obstructive atelectasis performance change (eg, 75.9% to 92.6%) tied to split perfusion timelines.
- The biopsy success claim (99.18%) tied to CEUS targeting plus ROSE cytopathology.
Minimal Needed Info to Proceed
To produce a rigorous, guideline-style evidence summary, the following are required:
- Target use: diagnosis vs staging vs treatment response.
- Lesion location: peripheral vs central pulmonary lesions.
- Comparator: CECT accuracy for the same reference standard.
- Clinical setting: pre-biopsy diagnostic workup vs percutaneous biopsy guidance vs intraoperative use.
Requested Focus
Please specify which output is needed:
- (A) “Audit and correct the text’s claims with verified evidence” (requires web-based source checking for each numeric claim), or
- (B) “Write an evidence-dense clinical integration section” (CEUS role in a lung cancer diagnostic pathway, including limitations and when CEUS is reasonable vs when CT is mandatory).